Condition

Familial Hypercholesterolemia - Homozygous clinical trials and research

• 2Clinical trials
• 12Countries

All recruiting trials (2)

• Evaluating inclisiran for children with a rare cholesterol condition

  This study is testing if a new cholesterol-lowering drug called inclisiran is safe and effective for children aged 2 to under 12 who have a rare condition that causes very high cholesterol levels.

  Recruiting at 19 sites Phase 3 Novartis · San Francisco, California and 18 other locations · NCT06597006

• Detecting Familial Hypercholesterolemia in Children

  This study is trying to find out if we can identify children with a genetic condition that causes high cholesterol so they can get early treatment and avoid heart problems later in life.

  Recruiting at 2 sites Institut Investigacio Sanitaria Pere Virgili · Reus, Tarragona and 1 other locations · NCT04370899

Related topics

Quick answers

How many Familial Hypercholesterolemia - Homozygous clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 12 countries. The most sites are in Spain (1 trial), Austria (1 trial), China (1 trial), Germany (1 trial), Greece (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →